Related Experiment Videos
Gene therapy: future therapy for erectile dysfunction
1Institute for Smooth Muscle Biology, Department of Urology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. christ@aecom.yu.edu
Current Urology Reports
|June 27, 2002
Summary
Gene therapy shows promise for treating erectile dysfunction by targeting numerous molecular pathways. Preclinical studies demonstrate significant success, suggesting potential for treating smooth muscle disorders.
Area of Science:
- Molecular Biology
- Urology
- Regenerative Medicine
Background:
- Advances in molecular biology and the Human Genome Project have paved the way for molecular medicine.
- Extensive knowledge of erection physiology and erectile dysfunction pathophysiology exists.
- Gene therapy for erectile dysfunction (ED) is now a distinct possibility.
Purpose of the Study:
- To highlight the goals and strategies of gene therapy for ED.
- To review the gene therapy strategies that have been employed.
- To assess the potential of gene therapy for ED treatment.
Main Methods:
- Review of preclinical gene therapy strategies and targets for ED.
- Examination of in vivo and in vitro studies on gene therapy for ED.
- Analysis of the physiological and pathophysiological mechanisms of ED.
Main Results:
- Numerous physiologically relevant molecular targets for gene therapy exist for ED.
- Preclinical gene therapy strategies have been largely successful in ameliorating compromised erectile function.
- Data from preclinical studies are impressive and encouraging.
Conclusions:
- Gene therapy for ED is a viable therapeutic possibility.
- Preclinical success suggests potential for clinical application.
- Successful clinical trials could establish gene therapy for ED as a proof of concept for treating human smooth muscle disorders.